Company Overview and News

53
Transocean Ltd. Looks Like a High-Risk, High-Reward Bet on Oil Prices

2018-07-07 investorplace
For drilling stocks like Transocean Ltd (NYSE:RIG), the past few years have shown just how risky the sector can be. RIG stock has dropped 72% in the past five years — and 91% in the last ten.
HAL RDS.B NE NBL RDS.A RDSB RDSA DO BP ESV SDRL RYDBF RYDAF RIG SGAZF

22
A Comparative Credit Analysis For Offshore Drilling Companies

2018-06-26 seekingalpha
Diamond Offshore and Transocean emerge as best picks in the offshore drilling sector based on the comparative analysis.
DO RDC NE ESV NOBGF N21 NOBGY RIG

5
NE / Noble Corporation plc 8-K (Current Report)

2018-06-22 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
NE

11
Noble: Improving Industry Conditions To Benefit The Company

2018-06-21 seekingalpha
Noble boasts one of the largest and most diversified fleets in the industry, able to work in a variety of different offshore environments.
PGNPQ NE NOBGF N21 NOBGY

11
Attempting To Crack The Noble Riddle

2018-06-18 seekingalpha
Noble's June fleet status is more evidence that an ultra-slow rig recovery is at hand, especially in the jack-up segment.
NE PGNPQ NOBGF N21 NOBGY BDRLF

93
Revamping Or Starting A Portfolio Now

2018-06-16 seekingalpha
Old economy, high capital, no moat is a catastrophe waiting to happen - sell your grandpa's stocks.
LMT NE NOBGF SPWR CAT TWX SW GOOG TWC EXAS SWIR ESV GOOGL N21 NOBGY NTR RIG

95
Seadrill Will Emerge From Chapter 11 In The First Half Of July

2018-06-08 seekingalpha
In recent months, I’ve been often asked about when Seadrill (SDRL) will emerge from Chapter 11. Prior to June 7, 2018, we only had a vague timeline for this event so such a question could not have been answered. Now, we have an official announcement from the company.
NE ESV NOBGF N21 NOBGY SDRL DTK RIG

16
Noble Corp.: Discussing June Fleet Status Report

2018-06-08 seekingalpha
No new contracts are reported. Potentially, Noble Corp.'s drillships lost a bid to Rowan Relentless for an Exxon Mobil job.
NE NOBGF N21 XOM NOBGY

16
Rowan Gets Drillship Contract From Exxon Mobil

2018-06-08 seekingalpha
The rig is hired by Exxon Mobil for an 80-day work in the Gulf of Mexico with four one-well priced options.
NE NOBGF XOM N21 NOBGY

100
Jack-Up Competition Intensifies

2018-06-04 seekingalpha
I wrote about the newbuild overhang in the jack-up market back in March. Now these rigs may slowly start getting to market.
SDLP NE PGNPQ NOBGF HERO ESV PACDQ N21 NOBGY SDRL BDRLF RIG HEROQ

17
Transocean And The Floaters Business - Some Thoughts

2018-05-23 seekingalpha
Even though you may think otherwise, the offshore drilling industry is not doing exceptionally fantastic, though oil prices have been ultra-bullish recently.
NE NOBGF N21 NOBGY RIG ORIG

12
Offshore Drillers: If Not Now, When?

2018-05-18 seekingalpha
For some time now I have been bullish of Noble Corp (NE), Diamond Offshore (DO), and Transocean (RIG). I have encouraged readers to buy their distressed debt as well as the washed out stocks of these companies. I admit I have been early in my calls on offshore drillers. But in time, I believe I will be proven correct on all of them. With the recent price action we are seeing in both oil prices, as well as in the language from the management of offshore drillers, it's hard to deny things are turning around.
NE NOBGF N21 NOBGY RIG

15
Trading Volatile Oil Services Stocks Is Challenging Even As Crude Oil Futures Set New Multiyear Highs

2018-05-14 seekingalpha
Nymex crude oil futures have been above their technical ‘reversion to the mean’ since 2018 began.
DO NE NOBGF N21 NOBGY MDR RIG MCDFF SGAZF

10
Noble Corp.: Entering An Early Stage Of A Long-Trend Reversal

2018-05-14 seekingalpha
Noble Corp. on Wednesday reported a first-quarter loss of $142 million, on revenues of $235.2 million.
NE NOBGF N21 NOBGY

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to NE / Noble Corporation plc on message board site Silicon Investor.

Fake News Wennerstrom Semi Equipment Analysis
Books, Movies, Food, Wine, and Whatever Boeing keeps setting new highs! When will it split?
Netflix (NFLX) Dutch Central Bank Sale Announcement Imminent?
Ratu0027s Nest - Chronicles of Collapse Silicon Investor - New feature discussion
Laughter is the Best Medicine - Tell us a joke The New Qualcomm - write what you like thread.
CUSIP: G65431101